Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

BMC Cancer201717:584

https://doi.org/10.1186/s12885-017-3577-x

Received: 27 July 2016

Accepted: 22 August 2017

Published: 29 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jul 2016 Submitted Original manuscript
12 Dec 2016 Reviewed Reviewer Report - Ryan Sullivan
12 Dec 2016 Reviewed Reviewer Report - Rodabe Amaria
29 Dec 2016 Reviewed Reviewer Report - Bonnie Elyssa Gould Rothberg
9 Jan 2017 Reviewed Reviewer Report - Ian Watson
12 Apr 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 2
12 Apr 2017 Submitted Manuscript version 2
6 Jul 2017 Reviewed Reviewer Report - Ryan Sullivan
6 Jul 2017 Reviewed Reviewer Report - Bonnie Elyssa Gould Rothberg
10 Jul 2017 Reviewed Reviewer Report - Ian Watson
9 Aug 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 3
9 Aug 2017 Submitted Manuscript version 3
18 Aug 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 4
18 Aug 2017 Submitted Manuscript version 4
Publishing
22 Aug 2017 Editorially accepted
29 Aug 2017 Article published 10.1186/s12885-017-3577-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital

Advertisement